[ report an error in this record ]basket (0): add | show Print this page

Attenuation of Nicotine Effects on A549 Lung Cancer Cells by Synthetic α7 nAChR Antagonists APS7-2 and APS8-2
Joukhan, A.; Kononenko, V.; Bele, T.; Dolenc, M.S.; Peigneur, S.; Pinheiro-Junior, E.L.; Tytgat, J.; Turk, T.; Krizaj, I.; Drobne, D. (2024). Attenuation of Nicotine Effects on A549 Lung Cancer Cells by Synthetic α7 nAChR Antagonists APS7-2 and APS8-2. Mar. Drugs 22(4): 147. https://dx.doi.org/10.3390/md22040147
In: Marine Drugs. Molecular Diversity Preservation International (MDPI): Basel. ISSN 1660-3397; e-ISSN 1660-3397, more
Peer reviewed article  

Available in  Authors 

Author keywords
    marine toxin;nicotinic acetylcholine receptor;nAChR antagonist;aps7-2;aps8-2;proliferation;delivery;analogs;salt

Authors  Top 
  • Joukhan, A.
  • Kononenko, V.
  • Bele, T.
  • Dolenc, M.S.
  • Peigneur, S., more
  • Pinheiro-Junior, E.L., more
  • Tytgat, J.
  • Turk, T.
  • Krizaj, I.
  • Drobne, D.

Abstract
    Nicotine binds to nicotinic acetylcholine receptors (nAChRs) that are overexpressed in different cancer cells, promoting tumor growth and resistance to chemotherapy. In this study, we aimed to investigate the potential of APS7-2 and APS8-2, synthetic analogs of a marine sponge toxin, to inhibit nicotine-mediated effects on A549 human lung cancer cells. Our electrophysiological measurements confirmed that APS7-2 and APS8-2 act as alpha 7 nAChR antagonists. APS8-2 showed no cytotoxicity in A549 cells, while APS7-2 showed concentration-dependent cytotoxicity in A549 cells. The different cytotoxic responses of APS7-2 and APS8-2 emphasize the importance of the chemical structure in determining their cytotoxicity on cancer cells. Nicotine-mediated effects include increased cell viability and proliferation, elevated intracellular calcium levels, and reduced cisplatin-induced cytotoxicity and reactive oxygen species production (ROS) in A549 cells. These effects of nicotine were effectively attenuated by APS8-2, whereas APS7-2 was less effective. Our results suggest that APS8-2 is a promising new therapeutic agent in the chemotherapy of lung cancer.

All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Authors